The MM-II trial was carried out in partnership with Israel-based Moebius Medical and included 397 patients in the US, Europe, ...

Revenue from operations increased 10% YoY on the back of strong deal wins and strong growth in key geographies and verticals ...

The company’s net non-performing assets (NPAs) stood at 1.46% as of March 2025, up from 0.99% in the same quarter last year ...

Revenue in the quarter was at ₹15,213 crore, recording a 2.4% year-on-year growth over the same quarter a year ago ...

Macrotech Developers Ltd, India’s leading realty player, has reported a 38.5% year-on-year (YoY) increase in net profit for ...

The firm won a construction order worth ₹85.43 crore from Yucca Promoters LLP for a commercial building project in Pune.

The contract given by MCL is regarding detailed engineering and PMC services for development of rail connectivity ...

SBI Life Insurance announced its earnings and stated that its net profit for the quarter ended March 2025 came in at ₹813.50 ...

Once again, the decision to cut repo rates by 25 bps in April 2025 meeting was unanimous with all the 6 members of the MPC ...

The Net Interest Income (NII) of the company for the quarter ending March 2025 was ₹365.3 crore, a 6.3% YoY increase ...

Phytonadione, is used to treat blood clotting disorders by facilitating the proper synthesis of clotting factors II, VII, IX, ...

BPCL informed that the joint venture will tackle several pressing environmental setbacks. This includes management of ...